Genetic factors in the development and progression of chronic kidney disease;Genetyczne czynniki ryzyka rozwoju i progresji przewlekłej choroby nerek

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 50-57

  Kiliś Pstrusińska, Katarzyna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Chronic kidney disease; Genetic factors

Indexed keywords

CHRONIC KIDNEY FAILURE; GENETICS; HUMAN; REVIEW; RISK FACTOR;

HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 77950388209     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Arar N. H., Voruganti V. S., Nath S. D., Thameem F., Bauer R., Cole S. A., Blangero J., MacCluer J. W., Comuzzie A. G., Abboud H. E.: A genome-wide search for linkage to chronic kidney disease in a community-based sample: the SAFHS. Nephrol. Dial. Transplant., 2008;23:3184-3191
2. Atkins R. C., Polkinghorne K. R., Briganti E. M., Shaw J. E., Zimmet P. Z., Chadban S. J.: Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Kidney Int., 2004; Suppl. 92: S22-S24
3. Babel N., Gabdrakhmanova L., Hammer M. H., Schoenemann C., Skrypnikov V., Poliak N., Volk H. D., Reinke P.: Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease. J. Nephrol., 2006;19:802-807 (Pubitemid 46415987)
4. Bantis C., Ivens K., Kreusser W., Koch M., Klein-Vehne N., Grabensee B., Heering P.: Influence of genetic polymorphisms of the reninangiotensin system on IgA nephropathy. Am. J. Nephrol., 2004;24:258-267 (Pubitemid 38456637)
5. Beerman I., Novak J., Wyatt R. J., Julian B. A., Gharavi A. G.: The genetics of IgA nephropathy. Nat. Clin. Pract. Nephrol., 2007;3:325-338 (Pubitemid 46834885)
6. Berthoux F. C., Berthoux P., Mariat C., Thibaudin L., Afiani A., Linossier M. T.: CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: the 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis. Kidney Int., 2006;69:565-572 (Pubitemid 43164451)
7. Bicanski B., Wenderdel M., Mertens P. R., Senderek J., Panzer U., Steinmetz O., Stahl R. A., Cerullo G., Diletta Torres D., Schena F. P., Zerres K., Floege J.: PDGF-B gene single-nucleotide polymorphisms are not predictive for disease onset or progression of IgA nephropathy. Clin. Nephrol., 2007;67:65-72 (Pubitemid 46322557)
8. *2) associated with nephropathy in diabetes mellitus. Hum. Genet., 1996;97:369-374
9. Brown D. M., Provoost A. P., Daly M. J., Lander E. S., Jacob H. J.: Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat. Genet., 1996;12:44-51 (Pubitemid 26011318)
10. Buraczyńska M., Ksia̧żek P., Drop A., Załuska W., Spasiewicz D., Ksia̧żek A.: Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol. Dial. Transplant., 2006;21:979-983
11. Chow K. M., Wong T. Y., Li P. K.: Genetics of common progressive renal disease. Kidney Int., 2005; Suppl. 94: S41-S45
12. Coll E., Cormand B., Campos B., González-Núnez D., Inigo P., Botey A., Poch E.: Association of TGF-β1 polymorphisms with chronic renal disease. J. Nephrol., 2004;17:794-799 (Pubitemid 41158299)
13. DeWan A. T., Arnett D. K., Atwood L. D., Province M. A., Lewis C. E., Hunt S. C., Eckfeldt J.: A genome scan for renal function among hypertensives: the HyperGEN study. Am. J. Hum. Genet., 2001;68:136-144 (Pubitemid 32048368)
14. Donadio J. V., Grande J. P.: IgA nephropathy. N. Engl. J. Med., 2002;347:738-748 (Pubitemid 35203906)
15. Doria A., Onuma T., Gearin G., Freire M. B., Warram J. H., Krolewski A. S.: Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension, 1996;27:1134-1139 (Pubitemid 26140671)
16. Eikmans M., Aben J. A., Koop K., Baelde H. J., de Heer E., Bruijn J. A.: Genetic factors in progressive renal disease: the good ones, the bad ones and the ugly ducklings. Nephrol. Dial. Transplant., 2006;21:257-260 (Pubitemid 43159974)
17. El Nahas M.: The global challenge of chronic kidney disease. Kidney Int., 2005;68:2918-2929 (Pubitemid 43251055)
18. Freedman B. I., Hicks P. J., Bostrom M. A., Cunningham M. E., Liu Y., Divers J., Kopp J. B., Winkler C. A., Nelson G. W., Langefeld C. D., Bowden D. W.: Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int., 2009;75:736-745
19. Freedman B. I., Soucie J. M., McClellan W. M.: Family history of end-stage renal disease among incident dialysis patients. J. Am. Soc. Nephrol., 1997;8:1942-1945 (Pubitemid 28185453)
20. Freedman B. I., Volkova N. V., Satko S. G., Krisher J., Jurkovitz C., Soucie J. M., McClellan W. M.: Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am. J. Nephrol., 2005;25:529-535 (Pubitemid 41816046)
21. Garg A. X., Kiberd B. A., Clark W. F., Haynes R. B., Clase C. M.: Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int., 2002;61:2165-2175 (Pubitemid 34539334)
22. Gharavi A. G., Ahmad T., Wong R. D., Hooshyar R., Vaughn J., Oller S., Frankel R. Z., Bruggeman L. A., D'Agati V. D., Klotman P. E., Lifton R. P.: Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc. Natl. Acad. Sci. USA, 2004;101:2488-2493 (Pubitemid 38269338)
23. Gharavi A. G., Yan Y., Scolari F., Schena F. P., Frasca G. M., Ghiggeri G. M., Cooper K., Amoroso A., Viola B. F., Battini G., Caridi G., Canova C., Farhi A., Subramanian V., Nelson-Williams C., Woodford S., Julian B. A., Wyatt R. J., Lifton R. P.: IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat. Genet., 2000;26:354-357
24. Grainger D. J., Heathcote K., Chiano M., Snieder H., Kemp P. R., Metcalfe J. C., Carter N. D., Spector T. D.: Genetic control of the circulating concentration of transforming growth factor type β1. Hum. Mol. Genet., 1999;8:93-97 (Pubitemid 29039053)
25. Gumprecht J., Zychma M. J., Grzeszczak W., Zukowska-Szczechowska E., End Stage Renal Disease Study Group: Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. Kidney Int., 2000;58:513-519 (Pubitemid 30620000)
26. Gumprecht J., Zychma M. J., Moczulski D. K., Gosek K., Grzeszczak W.: Family history of end-stage renal disease among hemodialyzed patients in Poland. J. Nephrol., 2003;16:511-515 (Pubitemid 38120459)
27. Harjutsalo V., Katoh S., Sarti C., Tajima N., Tuomilehto J.: Populationbased assessment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes, 2004;53:2449-2454 (Pubitemid 39145602)
28. Hillege H. L., Janssen W. M., Bak A. A., Diercks G. F., Grobbee D. E., Crijns H. J., Van Gilst W. H., De Zeeuw D., De Jong P. E., Prevend Study Group: Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J. Intern. Med., 2001;249:519-526 (Pubitemid 32823860)
29. Hohenfellner K., Wingen A. M., Nauroth O., Wühl E., Mehls O., Schaefer F.: Impact of ACE I/D gene polymorphism on congenital renal malformations. Pediatr. Nephrol., 2001;16:356-361 (Pubitemid 32366671)
30. Hsu C. C., Kao W. H., Coresh J., Pankow J. S., Marsh-Manzi J., Boerwinkle E., Bray M. S.: Apolipoprotein E and progression of chronic kidney disease. JAMA, 2005;293:2892-2899 (Pubitemid 41029143)
31. Imperatore G., Hanson R. L., Pettitt D. J., Kobes S., Bennett P. H., Knowler W. C: Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes, 1998;47:821-830 (Pubitemid 28201814)
32. Iseki K., Kinjo K., Iseki C., Takishita S.: Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am. J. Kidney Dis., 2004;44:806-814 (Pubitemid 39445912)
33. Iyengar S. K., Fox K. A., Schachere M., Manzoor F., Slaughter M. E., Covic A. M., Orloff S. M., Hayden P. S., Olson J. M., Schelling J. R., Sedor J. R.: Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy. J. Am. Soc. Nephrol., 2003;14(Suppl. 2):S195-S201 (Pubitemid 36750518)
34. Iyengar S. K., Freedman B. I., Sedor J. R.: Mining the genome for susceptibility to diabetic nephropathy: the role of large-scale studies and consortia. Semin. Nephrol., 2007;27:208-222 (Pubitemid 46550309)
35. Jafar T. H., Stark P. C., Schmid C. H., Landa M., Maschio G., de Jong P. E., de Zeeuw D., Shahinfar S., Toto R., Levey A. S.; AIPRD Study Group: Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann. Intern. Med., 2003;139:244-252
36. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis., 2002;39(Suppl. 1):S1-S266
37. Kao W. H., Klag M. J., Meoni L. A., Reich D., Berthier-Schaad Y., Li M., Coresh J., Patterson N., Tandon A., Powe N. R., Fink N. E., Sadler J. H., Weir M. R., Abboud H. E., Adler S. G., Divers J., Iyengar S. K., Freedman B. I., Kimmel P. L., Knowler W. C., Kohn O. F., Kramp K., Leehey D. J., Nicholas S. B., Pahl M. V., Schelling J. R., Sedor J. R., Thornley-Brown D., Winkler C. A., Smith M. W., Parekh R. S.: Family Investigation of Nephropathy and Diabetes Research Group: MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet., 2008;40:1185-1192
38. Khalil M. S., El Nahas A. M., Blakemore A. I.: Transforming growth factor-β1 SNPs: genetic and phenotypic correlations in progressive kidney insufficiency. Nephron Exp. Nephrol., 2005;101:e31-e41 (Pubitemid 41208899)
39. Klahr S., Morrissey J.: Progression of chronic renal disease. Am. J. Kidney Dis., 2003;41(Suppl. 1):S3-S7 (Pubitemid 36278335)
40. Kopp J. B., Smith M. W., Nelson G. W., Johnson R. C., Freedman B. I., Bowden D. W., Oleksyk T., McKenzie L. M., Kajiyama H., Ahuja T. S., Berns J. S., Briggs W., Cho M. E., Dart R. A., Kimmel P. L., Korbet S. M., Michel D. M., Mokrzycki M. H., Schelling J. R., Simon E., Trachtman H., Vlahov D., Winkler C. A.: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet., 2008;40:1175-1184
41. Korstanje R., DiPetrillo K.: Unraveling the genetics of chronic kidney disease using animal models. Am. J. Physiol. Renal. Physiol., 2004;287:F347-F352 (Pubitemid 39095947)
42. Król E., Rutkowski B., Czarniak P., Kraszewska E., Lizakowski S., Szubert R., Czekalski S., Sułowicz W., Wiȩcek A.: Early detection of chronic kidney disease: results of the PolNef study. Am. J. Nephrol., 2009;29:264-273
43. Krolewski A. S., Poznik G. D., Placha G., Canani L., Dunn J., Walker W., Smiles A., Krolewski B., Fogarty D. G., Moczulski D., Araki S., Makita Y., Ng D. P., Rogus J., Duggirala R., Rich S. S., Warram J. H.: A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int., 2006;69:129-136 (Pubitemid 43117748)
44. Ksia̧żek P., Bednarek-Skublewska A., Buraczyńska M.: The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus. Med. Sci. Monit., 2004;10: BR47-BR51 (Pubitemid 38233059)
45. Leon J. M., Freedman B. I., Miller M. B., North K. E., Hunt S. C., Eckfeldt J. H., Lewis C. E., Kraja A. T., Djoussé L., Arnett D. K.: Genome scan of glomerular filtration rate and albuminuria: the HyperGEN study Nephrol. Dial. Transplant., 2007;22:763-771 (Pubitemid 46351683)
46. Lim C. S., Kim S. M., Oh Y. K., Kim Y. S., Chae D. W., Han J. S., Kim S., Lee J. S., Yoon H. J.: Association between the clara cell secretory protein (CC16) G38A polymorphism and the progression of IgA nephropathy. Clin. Nephrol., 2007;67:73-80 (Pubitemid 46322558)
47. Liu Y., Freedman B. I.: Genetics of progressive renal failure in diabetic kidney disease. Kidney Int., 2005; Suppl. 99: S94-S97
48. Loughrey B. V., Maxwell A. P., Fogarty D. G., Middleton D., Harron J. C., Patterson C. C., Darke C., Savage D. A.: An interleukin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine, 1998;10:984-988 (Pubitemid 29080694)
49. Lovati E., Richard A., Frey B. M., Frey F. J., Ferrari P.: Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int., 2001;60:46-54 (Pubitemid 32587538)
50. Luttropp K., Lindholm B., Carrero J. J., Glorieux G., Schepers E., Vanholder R., Schalling M., Stenvinkel P., Nordfors L.: Genetics/Genomics in chronic kidney disease - towards personalized medicine? Semin. Dial., 2009;22:417-422
51. Maruyama K., Yoshida M., Nishio H., Shirakawa T., Kawamura T., Tanaka R., Nakamura H., Iijima K., Yoshikawa N.: Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr. Nephrol., 2001;16:350-355 (Pubitemid 32366670)
52. Mathis B. J., Kim S. H., Calabrese K., Haas M., Seidman J. G., Seidman C. E., Pollak M. R.: A locus for inherited focal segmental glomerulosclerosis maps to chromosome 19q13. Kidney Int., 1998;53:282-286 (Pubitemid 28097844)
53. McClellan W., Speckman R., McClure L., Howard V., Campbell R. C., Cushman M., Audhya P., Howard G., Warnock D. G.: Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study. J. Am. Soc. Nephrol., 2007;18:1344-1352 (Pubitemid 46536922)
54. Mittal R. D., Manchanda P. K.: Association of interleukin (IL)-4 intron-3 and IL-6-174 G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics, 2007;59:159-165 (Pubitemid 46130794)
55. Mittal R. D., Manchanda P. K.: Is low-frequency distribution of TGF-β genotype associated with increased risk for end-stage renal disease? DNA Cell Biol., 2007;26:172-177 (Pubitemid 46557385)
56. Młynarski W., Wołkow P. P., Krolewski A. S.: Poszukiwanie genów dla nefropatii cukrzycowej: nowe kierunki. Przegla̧d Pediatryczny, 2003;33:97-104 (Pubitemid 36773451)
57. Moczulski D. K., Rogus J. J., Antonellis A., Warram J. H., Krolewski A. S.: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes, 1998;47:1164-1169 (Pubitemid 28294564)
58. Möller C. C., Pollak M. R., Reiser J.: The genetic basis of human glomerular disease. Adv. Chronic Kidney Dis., 2006;13:166-173
59. Nakajima K., Tanaka Y., Nomiyama T., Ogihara T., Ikeda F., Kanno R., Iwashita N., Sakai K., Watada H., Onuma T., Kawamori R.: RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care, 2003;26:892-898 (Pubitemid 36929361)
60. Nordfors L., Lindholm B., Stenvinkel P.: End-stage renal disease - not an equal opportunity disease: the role of genetic polymorphisms. J. Intern. Med., 2005;258:1-12 (Pubitemid 40904927)
61. Osterholm A. M., He B., Pitkaniemi J., Albinsson L., Berg T., Sarti C., Tuomilehto J., Tryggvason K.: Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int., 2007;71:140-145 (Pubitemid 46094687)
62. Panzer U., Schneider A., Steinmetz O. M., Wenzel U., Barth P., Reinking R., Becker J. U., Harendza S., Zahner G., Fischereder M., Krämer B. K., Schlöndorff D., Ostendorf T., Floege J., Helmchen U., Stahl R. A.: The chemokine receptor 5 A32 mutation is associated with increased renal survival in patients with IgA nephropathy. Kidney Int., 2005;67:75-81 (Pubitemid 40019228)
63. Pettitt D. J., Saad M. F., Bennett P. H., Nelson R. G., Knowler W. C.: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 1990;33:438-443 (Pubitemid 20220945)
64. Powe N. R.: Reverse race and ethnic disparities in survival increase with severity of chronic kidney disease: what does this mean? Clin. J. Am. Soc. Nephrol., 2006;1:905-906
65. Poyan Mehr A., Siegel A. K., Kossmehl P., Schulz A., Plehm R., de Bruijn J. A., de Heer E., Kreutz R.: Early onset albuminuria in Dahl rats is a polygenetic trait that is independent from salt loading. Physiol. Genomics, 2003;14:209-216 (Pubitemid 37345229)
66. Prasad P., Tiwari A. K., Kumar K. M., Ammini A. C., Gupta A., Gupta R., Thelma B. K.: Association of TGF 1, TNFa, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med. Genet., 2007;8:20
67. Qualheim R. E., Rostand S. G., Kirk K. A., Rutsky E. A., Luke R. G.: Changing patterns of end-stage renal disease due to hypertension. Am. J. Kidney Dis., 1991;18:336-343
68. Quinn M., Angelico M. C., Warram J. H., Krolewski A. S.: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia, 1996;39:940-945 (Pubitemid 26249113)
69. Rao M., Wong C., Kanetsky P., Girndt M., Stenvinkel P., Reilly M., Raj D. S.: Cytokine gene polymorphism and progression of renal and cardiovascular diseases. Kidney Int., 2007;72:549-556 (Pubitemid 47312798)
70. Remuzzi G., Benigni A., Remuzzi A.: Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J. Clin. Invest., 2006;116:288-296 (Pubitemid 43228342)
71. Romundstad S., Holmen J., Kvenild K., Hallan H., Ellekjaer H.: Microalbuminuria and all-cause mortality in 2, 089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am. J. Kidney Dis., 2003;42:466-473 (Pubitemid 37048122)
72. Rostand S. G., Kirk K. A., Rutsky E. A., Pate B. A.: Racial differences in the incidence of treatment for end-stage renal disease. N. Engl. J. Med., 1982;306:1276-1279 (Pubitemid 12100210)
73. Ruggenenti P., Perna A., Zoccali C., Gherardi G., Benini R., Testa A., Remuzzi G.: Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen). J. Am. Soc. Nephrol., 2000;11:88-96 (Pubitemid 30020430)
74. Rutkowski B.: Przewlekła choroba nerek (PChN) - wyzwanie XXI wieku. Przew. Lek., 2007;2:80-88
75. Satko S. G., Freedman B. I.: The importance of family history on the development of renal disease. Curr. Opin. Nephrol. Hypertens., 2004;13:337-341 (Pubitemid 38582308)
76. Satko S. G., Freedman B. I., Moosavi S.: Genetic factors in end-stage renal disease. Kidney Int., 2005;94:S46-S49
77. Satko S. G., Sedor J. R., Iyengar S. K., Freedman B. I.: Familial clustering of chronic kidney disease. Semin. Dial., 2007;20:229-236
78. Tarver-Carr M. E., Powe N. R., Eberhardt M. S., LaVeist T. A., Kington R. S., Coresh J., Brancati F. L.: Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J. Am. Soc. Nephrol., 2002;13:2363-2370 (Pubitemid 34925247)
79. Turner S. T., Kardia S. L., Mosley T. H., Rule A. D., Boerwinkle E., de Andrade M.: Influence of genomic loci on measures of chronic kidney disease in hypertensive sibships. J. Am. Soc. Nephrol., 2006;17:2048-2055 (Pubitemid 44036189)
80. Vardarli I., Baier L. J., Hanson R. L., Akkoyun I., Fischer C., Rohmeiss P., Basci A., Bartram C. R., Van der Woude F. J., Janssen B.: Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int., 2002;62:2176-2183 (Pubitemid 35366173)
81. Wong T. Y., Poon P., Chow K. M., Szeto C. C., Cheung M. K., Li P. K.: Association of transforming growth factor-β (TGF-β) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney Int., 2003;63:1831-1835 (Pubitemid 36513330)
82. Wong T. Y., Poon P., Szeto C. C., Chan J. C., Li P. K.: Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int., 2000;57:632-638 (Pubitemid 30430656)
83. Woroniecki R. P., Kopp J. B.: Genetics of focal segmental glomerulosclerosis. Pediatr. Nephrol., 2007;22:638-644 (Pubitemid 46691517)
84. Yao Q., Nordfors L., Axelsson J., Heimbürger O., Qureshi A. R., Báràny P., Lindholm B., Lönnqvist F., Schalling M., Stenvinkel P.: Peroxisome pro life rator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy. Atherosclerosis, 2005;182:105-111 (Pubitemid 41188375)
85. Zhou L., Chen Y., Sun N., Liu X.: Family history of hypertension and arterial elasticity characteristics in healthy young people. Hypertens. Res., 2008;31:833-839 (Pubitemid 351895026)